Hormonal health

GLP-1 Medications and PCOS: What We Know So Far

Save

GLP-1 drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide are approved for weight and diabetes, not PCOS, but early studies suggest they may improve insulin resistance, cycles, and ovulation. Even a 5 percent to 10 percent weight change can restore periods in PCOS [2]. Evidence is limited, and the drugs are paused before pregnancy.

Last updated: July 2026

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

How might GLP-1 drugs help PCOS?

Insulin resistance is a core driver of PCOS, present in a large share of women with the condition regardless of body size 1. GLP-1 receptor agonists lower blood sugar, slow digestion, and reduce appetite, which can lead to meaningful weight loss and better insulin sensitivity 4.

Because excess weight and high insulin push the ovaries to make more androgens, easing them can help periods return and may lower some long-term risks 1. Our explainer on how these drugs work covers the mechanism, and our overview of insulin resistance shows why it matters so much in PCOS. Even so, no GLP-1 drug is yet approved with PCOS on its label.

What does the research actually show?

Evidence for GLP-1 drugs in PCOS is early and comes mostly from small, short studies. These trials suggest weight loss, improved insulin measures, and more regular cycles, but they are too small to prove long-term benefit or safety in PCOS specifically 2.

The 2023 international guideline recognizes anti-obesity medications as an option for some women when lifestyle changes are not enough, while stressing that large trials are still needed 2. Weight loss of 5 percent to 10 percent of body weight, however it is achieved, is what tends to move cycles and ovulation 3. According to reproductive-medicine guidance, losing excess weight before conception can improve fertility and pregnancy outcomes 3. For now, GLP-1 use in PCOS is largely off-label.

What about fertility and pregnancy?

Weight loss can restore ovulation, so some women become more fertile on GLP-1 drugs, sometimes unexpectedly. That matters because these medications are generally stopped before trying to conceive: safety in pregnancy has not been established, and manufacturers advise pausing them well beforehand 3. Because these drugs can quietly restore fertility, an unplanned pregnancy is a real possibility for someone who assumed PCOS made conception unlikely.

If pregnancy is the near-term goal, proven ovulation treatments remain first-line, as our guide to PCOS and fertility explains. In adolescence, first-line PCOS care still centers on lifestyle and cycle regulation rather than these newer drugs 2. A clinician can help time any weight-focused treatment around family planning.

What are the trade-offs and side effects?

Side effects are common and can be significant. Nausea, vomiting, constipation, and diarrhea affect many users, especially when starting or increasing the dose, as our guide to GLP-1 side effects describes 4.

Cost and access are real barriers, and weight often returns when the medication stops, with many people regaining much of what they lost, which our piece on whether you stay on these drugs long term explores. For women with PCOS, that raises hard questions about years-long treatment and what happens afterward. These are not quick fixes, and they sit alongside, not instead of, nutrition, movement, and sleep. Shared decision-making with a clinician tends to matter more than any single number on a scale.

When GLP-1 questions in PCOS need a clinician

A primary care or gynecology clinician can look at your whole PCOS picture, including weight, insulin resistance, cycles, and whether you hope to conceive, and weigh whether a GLP-1 medication fits 2. Blood sugar, thyroid, and other causes of symptoms are usually checked first, since not every irregular cycle is PCOS.

Because the evidence is still young, an honest conversation about benefits, costs, and the plan if you stop matters as much as the prescription itself. Because PCOS affects roughly 1 in 10 women of reproductive age 1, these have become common questions in primary care. Gale can help you prepare questions for that visit.

Common questions

No. GLP-1 drugs such as semaglutide and tirzepatide are approved for type 2 diabetes and weight management. Their use in PCOS is off-label and based on early, still-limited evidence.

It might help. By lowering weight and improving insulin sensitivity, these drugs can make ovulation and periods more regular for some people, but results vary and it is not guaranteed.

Generally no. These medications are usually stopped before conception because their safety in pregnancy has not been established. A clinician can advise on timing if you are planning a pregnancy.

Weight often returns after stopping, so long-term planning is part of the decision. This is a common and important discussion to have with a clinician before starting.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

GLP-1 medications and PCOS: when to check in

  • —Severe or persistent vomiting, or being unable to keep fluids down, while on a GLP-1 medication is a reason to seek same-day care.
  • —Severe abdominal pain that does not ease can signal pancreatitis or gallbladder problems and is a reason to seek urgent medical review.
  • —A positive pregnancy test while taking a GLP-1 drug is a reason to contact your clinician promptly.
  • —Signs of dehydration such as dizziness, dark urine, or very low urine output are a reason to seek clinician review.

This article is general health education, not medical advice. Whether a GLP-1 medication is appropriate for your PCOS should be decided with a primary care or gynecology clinician who knows your health history.

References

  1. 1.Office on Women's Health (U.S. HHS) (2025). Polycystic ovary syndrome. Office on Women's Health (womenshealth.gov), U.S. HHS. link ✓PCOS affects an estimated 5 to 10 percent of women of reproductive age and is driven by insulin resistance and higher androgens, independent of body size
  2. 2.Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/clinem/dgad463 ✓Positions lifestyle as first-line, notes anti-obesity medications as an option when lifestyle is insufficient, and emphasizes adolescence-appropriate care and the limits of current evidence
  3. 3.Practice Committee of the American Society for Reproductive Medicine (2021). Obesity and reproduction: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2021.08.018 ✓Weight loss of about 5 to 10 percent can improve ovulation and fertility, and losing excess weight before conception improves pregnancy outcomes
  4. 4.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656 ✓Insulin resistance drives many PCOS features, supporting the rationale for treatments that improve insulin sensitivity and weight

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library